Making available information from studies sponsored by the pharmaceutical industry: some current practices
| Autor: | Susan Todd, Steven A. Julious, Stephen Pyke, Michael O'Kelly, James Matcham, Simon Day, Jorgen Seldrup |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Pharmacology
Statistics and Probability medicine.medical_specialty Operations research business.industry Process (engineering) Alternative medicine Publication bias Public relations Transparency (behavior) humanities Clinical trial Consistency (negotiation) medicine Pharmacology (medical) business Pharmaceutical industry |
| Zdroj: | Pharmaceutical Statistics. 10:60-69 |
| ISSN: | 1539-1604 |
| DOI: | 10.1002/pst.430 |
| Popis: | Since the web-based registry ClinicalTrials.gov was launched on 29 February 2000, the pharmaceutical industry has made available an increasing amount of information about the clinical trials that it sponsors. The process has been spurred on by a number of factors including a wish by the industry to provide greater transparency regarding clinical trial data; and has been both aided and complicated by the number of institutions that have a legitimate interest in guiding and defining what should be made available. This article reviews the history of this process of making information about clinical trials publicly available. It provides a reader's guide to the study registries and the databases of results; and looks at some indicators of consistency in the posting of study information. Copyright © 2010 John Wiley & Sons, Ltd. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text